Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18645975 | Genderless Aseptic Connector | April 2024 | December 2024 | Allow | 8 | 1 | 0 | No | No |
| 18638166 | MEDICAMENT DELIVERY DEVICE | April 2024 | February 2025 | Allow | 10 | 1 | 0 | Yes | No |
| 18394502 | FLUIDICS MANAGEMENT SYSTEM | December 2023 | October 2024 | Allow | 10 | 2 | 0 | Yes | No |
| 18502803 | DEVICES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISCOGENIC BACK PAIN | November 2023 | September 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18552893 | ASPIRATION AND INJECTION DEVICES | September 2023 | July 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18238348 | INFUSION DEVICE AND METHOD | August 2023 | December 2024 | Allow | 15 | 1 | 1 | No | No |
| 18229963 | ENDOVASCULAR REMOTELY STEERABLE GUIDEWIRE CATHETER | August 2023 | September 2024 | Allow | 13 | 1 | 0 | No | No |
| 18358147 | ACTIVATION SYSTEM AND METHOD FOR ON-BODY MEDICAL DEVICES | July 2023 | December 2024 | Allow | 17 | 1 | 1 | Yes | No |
| 18358229 | FLOW INDICATOR FOR AN INFUSION PUMP | July 2023 | August 2024 | Allow | 13 | 1 | 0 | No | No |
| 18141680 | APPARATUS AND METHODS FOR DISPENSING ORAL TRANSMUCOSAL DOSAGE FORMS | May 2023 | March 2025 | Abandon | 23 | 3 | 0 | No | No |
| 18139698 | Integrated Pump Control For Dynamic Control Of Plasma Field | April 2023 | March 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18043873 | CATHETERS ADAPTED FOR AGENT DELIVERY | March 2023 | February 2025 | Allow | 24 | 2 | 1 | No | No |
| 18041104 | Features for Angiography Syringe | February 2023 | March 2024 | Allow | 14 | 2 | 1 | No | No |
| 18107422 | HIATAL HERNIA TREATMENT | February 2023 | May 2024 | Allow | 15 | 1 | 1 | Yes | No |
| 18073126 | INTRAVENOUS PRIMING CAP | December 2022 | February 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 18048783 | DRUG DEPOT DELIVERY SYSTEM AND METHOD | October 2022 | February 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17931162 | DRUG DELIVERY DEVICE AND METHOD | September 2022 | November 2023 | Allow | 14 | 2 | 0 | Yes | No |
| 17901360 | INFUSING DRUG SOLUTION DIRECTLY INTO BRAIN FLUID | September 2022 | April 2025 | Allow | 31 | 4 | 0 | Yes | Yes |
| 17860574 | IN VIVO POSITIONABLE FILTRATION DEVICES AND METHODS RELATED THERETO | July 2022 | March 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 17734551 | METHOD FOR ELECTROPORATION CONTROLLED BY ELECTRICAL IMPEDENCE MEASUREMENTS | May 2022 | January 2024 | Allow | 20 | 1 | 1 | Yes | No |
| 17640862 | TRACK AND LOCKING MECHANISMS FOR INJECTION DEVICE | March 2022 | February 2024 | Allow | 24 | 1 | 0 | Yes | No |
| 17673675 | INJECTION DEVICES AND SYSTEMS AND METHODS FOR USING THEM | February 2022 | February 2024 | Allow | 24 | 1 | 1 | Yes | No |
| 17666138 | Implants for Localized Drug Delivery and Methods of Use Thereof | February 2022 | November 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17457722 | INTRAOCULAR GAS INJECTOR | December 2021 | June 2023 | Allow | 19 | 1 | 0 | No | No |
| 17542218 | ACTIVATION SYSTEM AND METHOD FOR ON-BODY MEDICAL DEVICES | December 2021 | May 2023 | Allow | 17 | 1 | 0 | No | No |
| 17457006 | SYSTEM AND METHODS FOR INTRACRANIAL VESSEL ACCESS | November 2021 | July 2023 | Allow | 20 | 1 | 0 | Yes | No |
| 17526268 | MEDICAMENT DELIVERY DEVICE | November 2021 | January 2024 | Allow | 26 | 1 | 1 | Yes | No |
| 17520397 | MALE LUER WITH FLUID PATH AND VENT PATH SEALS | November 2021 | April 2025 | Allow | 41 | 2 | 0 | No | No |
| 17449221 | OCCLUDABLE INTRODUCER NEEDLE | September 2021 | March 2023 | Allow | 18 | 1 | 0 | Yes | No |
| 17404954 | SYRINGE ADAPTER FOR MEDICATION | August 2021 | May 2022 | Allow | 9 | 2 | 0 | Yes | No |
| 17391685 | CANNULAS HAVING WALL STRENGTHENING FEATURES, AND RELATED SYSTEMS AND METHODS | August 2021 | April 2025 | Allow | 45 | 4 | 1 | Yes | No |
| 17340840 | CHAMBERED DISPENSING DEVICES AND METHODS | June 2021 | May 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17309290 | Syringe For Storing And Dispensing A Material | May 2021 | March 2025 | Allow | 46 | 4 | 0 | No | No |
| 17241927 | MICROPROJECTION ARRAYS WITH ENHANCED SKIN PENETRATING PROPERTIES AND METHODS THEREOF | April 2021 | May 2024 | Allow | 37 | 3 | 0 | Yes | No |
| 17286210 | Magnetic Delivery System and Hydrogel Fixative for Therapeutic Cells | April 2021 | December 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 17280399 | AUTO-INJECTOR | March 2021 | December 2024 | Allow | 45 | 2 | 0 | Yes | No |
| 17278894 | FIXING DEVICE FOR FIXING A CATHETER ASSEMBLY TO A PATIENT | March 2021 | January 2025 | Allow | 46 | 5 | 0 | No | No |
| 17270616 | FLUID INJECTOR SYSTEM WITH IMPROVED RATIO PERFORMANCE | February 2021 | June 2025 | Allow | 51 | 1 | 1 | Yes | No |
| 17150086 | METHOD AND SYSTEM FOR NEUROHYDRODISSECTION | January 2021 | July 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 17259976 | PLATE ELECTRODES | January 2021 | May 2025 | Abandon | 52 | 1 | 1 | No | No |
| 17147041 | LOCKABLE ADAPTER ASSEMBLY | January 2021 | October 2024 | Allow | 45 | 3 | 0 | No | No |
| 17128122 | Syringe for Direct Use with Medical Ampoules and Vials | December 2020 | July 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17122881 | CATHETER HANDLE | December 2020 | January 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17252165 | PEN NEEDLE | December 2020 | November 2024 | Allow | 47 | 1 | 1 | No | No |
| 17101135 | SURGICAL ACCESS DEVICE WITH FIXATION MECHANISM | November 2020 | July 2024 | Allow | 44 | 1 | 1 | No | No |
| 16951987 | DRUG DELIVERY DEVICE HAVING A NEEDLE GUARD MECHANISM WITH A TUNABLE THRESHOLD OF RESISTANCE TO NEEDLE GUARD MOVEMENT | November 2020 | September 2023 | Allow | 34 | 8 | 0 | Yes | No |
| 17099925 | Active Injection Guide | November 2020 | July 2024 | Allow | 44 | 3 | 1 | Yes | No |
| 17098933 | MEDICATION DELIVERY SYSTEM WITH MASK | November 2020 | January 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17066867 | APPLICATOR FOR APPLYING A MICRONEEDLE DEVICE TO SKIN | October 2020 | January 2025 | Allow | 51 | 2 | 1 | No | No |
| 17060769 | Methods and Compositions for Restoring Homeostatic Capacity of a Subject | October 2020 | August 2024 | Allow | 46 | 5 | 1 | Yes | No |
| 17035851 | DRUG DELIVERY DEVICE AND METHODS OF DELIVERING A DRUG | September 2020 | December 2024 | Allow | 50 | 3 | 1 | Yes | No |
| 17035927 | DRUG DELIVERY DEVICE | September 2020 | April 2024 | Allow | 42 | 4 | 0 | Yes | No |
| 17033359 | HIATAL HERNIA TREATMENT | September 2020 | January 2023 | Allow | 27 | 1 | 1 | No | No |
| 17009874 | RELEASABLE SEAL FOR CATHETER SYSTEM | September 2020 | August 2022 | Allow | 24 | 1 | 0 | No | No |
| 16977213 | OPTIMIZING INITIAL ORGAN PRESERVATION | September 2020 | December 2024 | Allow | 51 | 2 | 1 | Yes | No |
| 17004753 | SUBMUCOSAL BIORESORBABLE DRUG ELUTING PLATFORM | August 2020 | April 2025 | Allow | 56 | 3 | 1 | Yes | No |
| 17002078 | INTRAOCULAR IMPLANT DELIVERY APPARATUS AND METHODS OF USE THEREOF | August 2020 | September 2023 | Abandon | 37 | 2 | 0 | No | No |
| 16998176 | PENILE INJECTION GUIDE AND COMPRESSION DEVICE | August 2020 | August 2023 | Allow | 36 | 1 | 0 | Yes | No |
| 16994151 | CONNECTION MECHANISM FOR AN AUXILIARY MODULE | August 2020 | June 2025 | Allow | 58 | 4 | 1 | Yes | No |
| 16992009 | Automated sequential injection and blood draw | August 2020 | May 2024 | Abandon | 45 | 2 | 0 | No | No |
| 16965865 | Surface Texturization for Rolling Diaphragm Syringe | July 2020 | February 2025 | Abandon | 54 | 6 | 1 | Yes | No |
| 16942459 | CATHETER SHAFT AND CATHETER AND METHOD FOR THE PRODUCTION THEREOF | July 2020 | April 2025 | Allow | 56 | 4 | 0 | No | No |
| 16918273 | Flow Indicator for an Infusion Pump | July 2020 | April 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16908387 | RIGID AND FLEXIBLE LAPAROSCOPIC MULTIPLE COMPONENT MATERIAL DISPENSING DEVICES AND METHODS | June 2020 | June 2024 | Allow | 48 | 2 | 1 | No | No |
| 16772229 | READY-TO-USE CRYORESISTANT INJECTION DEVICE | June 2020 | April 2023 | Abandon | 34 | 1 | 0 | No | No |
| 16889835 | STABILIZING AND SEALING CATHETER FOR USE WITH A GUIDING CATHETER | June 2020 | September 2022 | Allow | 28 | 1 | 0 | Yes | No |
| 16768635 | DEVICE FOR FACILITATING NEEDLE INJECTION | May 2020 | June 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16887239 | STABLE-FOAM DISPENSING DEVICE AND CARTRIDGE | May 2020 | September 2021 | Allow | 16 | 2 | 1 | Yes | No |
| 15929937 | METHOD AND DEVICE FOR SECLUDING A BODY VESSEL | May 2020 | September 2022 | Allow | 28 | 6 | 1 | Yes | No |
| 16760782 | Injection Device | April 2020 | November 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16860864 | LUER ADAPTOR WITH SAFETY LOCK AND RELATED DRAINAGE SYSTEMS | April 2020 | October 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16852788 | METHODS AND APPARATUS FOR TRANSFERRING PRESSURE DURING EXPRESSION OF HUMAN BREAST MILK | April 2020 | May 2024 | Allow | 48 | 3 | 0 | No | No |
| 16846801 | FEMALE SYRINGE BARREL, SYRINGE KIT, AND SYRINGE CONNECTION METHOD | April 2020 | February 2024 | Allow | 46 | 2 | 1 | Yes | No |
| 16811346 | COLOSTRUM COLLECTION DEVICE | March 2020 | July 2023 | Allow | 40 | 3 | 1 | Yes | No |
| 16811937 | SUB-ATMOSPHERIC WOUND THERAPY SYSTEMS AND METHODS | March 2020 | March 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16805081 | PERCUTANEOUS ACCESS DEVICE WITH ADJUSTABLE DEPTH STOP | February 2020 | January 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16643030 | SYSTEMS AND METHODS FOR DELIVERING AN AGENT TO A BREASTFEEDING CHILD | February 2020 | March 2025 | Allow | 60 | 4 | 1 | Yes | No |
| 16631036 | SAFETY SYRINGE | February 2020 | June 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16783428 | ACTIVE INJECTION GUIDE | February 2020 | April 2021 | Abandon | 14 | 1 | 0 | Yes | No |
| 16637124 | INTEGRATED PASSIVE SYRINGE NEEDLE SAFETY SYSTEM WITH TORQUED COMPRESSION SPRING AND MULTI-PART COLLAR | February 2020 | September 2020 | Allow | 7 | 1 | 0 | No | No |
| 16635770 | DEVICE FOR IMPLANTING OBJECTS UNDER THE SKIN | January 2020 | August 2023 | Abandon | 42 | 0 | 1 | No | No |
| 16730714 | Methods For Injecting Fluids | December 2019 | April 2024 | Allow | 51 | 2 | 1 | Yes | No |
| 16728072 | Sensor Arrangement for an Injection Device | December 2019 | January 2023 | Allow | 37 | 2 | 0 | Yes | No |
| 16727609 | MEDICAMENT DELIVERY DEVICE HAVING AN ACTIVATING MECHANISM | December 2019 | April 2024 | Allow | 52 | 2 | 1 | Yes | No |
| 16715105 | NONDISCONNECTABLE, SECURABLE CONNECTOR HAVING A CAPPING SLEEVE | December 2019 | April 2025 | Abandon | 60 | 5 | 1 | No | No |
| 16712264 | DISPENSER DEVICES AND METHODS | December 2019 | June 2023 | Abandon | 42 | 0 | 1 | Yes | No |
| 16698908 | CHEST TUBE VALVE | November 2019 | August 2023 | Abandon | 45 | 1 | 1 | Yes | No |
| 16690418 | Integrated Pump Control For Dynamic Control Of Plasma Field | November 2019 | January 2023 | Allow | 38 | 1 | 1 | Yes | No |
| 16688654 | IRRIGATION ASSEMBLY | November 2019 | July 2021 | Allow | 20 | 1 | 0 | Yes | No |
| 16611355 | MICROJET DRUG INJECTION DEVICE EQUIPPED WITH BACKFLOW PREVENTION VALVE | November 2019 | June 2022 | Allow | 31 | 1 | 0 | Yes | No |
| 16609816 | DOSING SYRINGE | October 2019 | October 2022 | Allow | 36 | 2 | 0 | Yes | No |
| 16666630 | DEVICE FOR TEMPORARY LOCAL APPLICATION OF FLUIDS | October 2019 | October 2022 | Allow | 35 | 2 | 0 | No | No |
| 16666120 | Anti-Extravasation Catheter | October 2019 | March 2022 | Abandon | 28 | 3 | 0 | No | No |
| 16660445 | Fluid-Delivery System, Device, and Adapter for Delivering Fluid to Tissue | October 2019 | October 2023 | Allow | 48 | 2 | 1 | Yes | No |
| 16660796 | Ultra-Low Waste Needle and Syringe System that Automatically and Passively Renders a Needle Safe During the Injection Process | October 2019 | December 2020 | Allow | 14 | 1 | 0 | Yes | No |
| 16593547 | MEDICAL TUBE CLEARANCE DEVICE | October 2019 | August 2024 | Allow | 58 | 3 | 0 | No | Yes |
| 16590654 | DRUG DEPOT DELIVERY SYSTEM AND METHOD | October 2019 | June 2022 | Allow | 33 | 1 | 0 | No | No |
| 16497502 | Adaptor for Connecting a Connector to a Drug Delivery Device | September 2019 | January 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16497515 | Adaptor for Connecting a Drug Delivery Device to a Connector | September 2019 | July 2023 | Allow | 45 | 4 | 0 | No | No |
| 16578187 | SYSTEM AND METHODS FOR INTRACRANIAL VESSEL ACCESS | September 2019 | August 2021 | Allow | 23 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LALONDE, ALEXANDRA ELIZABETH.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LALONDE, ALEXANDRA ELIZABETH works in Art Unit 3783 and has examined 311 patent applications in our dataset. With an allowance rate of 71.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 40 months.
Examiner LALONDE, ALEXANDRA ELIZABETH's allowance rate of 71.7% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by LALONDE, ALEXANDRA ELIZABETH receive 2.91 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LALONDE, ALEXANDRA ELIZABETH is 40 months. This places the examiner in the 9% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +36.2% benefit to allowance rate for applications examined by LALONDE, ALEXANDRA ELIZABETH. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 21.3% of applications are subsequently allowed. This success rate is in the 16% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 22.4% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 54.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 45% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 76.5% of appeals filed. This is in the 64% percentile among all examiners. Of these withdrawals, 69.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 63.3% are granted (fully or in part). This grant rate is in the 80% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.9% of allowed cases (in the 55% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.